Salarius Pharmaceuticals announced the adjournment of its 2025 Annual Meeting of Stockholders for soliciting additional votes.
The required quorum for the meeting's business transaction was not met, leading to the adjournment.
The Annual Meeting will be reconvened on December 31, 2025, virtually via live webcast.
Adjournment of Annual Meeting
The Annual Meeting was adjourned to gather additional votes for proposals.
Reconvened Meeting Date
The reconvened Annual Meeting is scheduled for December 31, 2025, virtually.
Encouragement to Vote
Stockholders from the record date are encouraged to vote online or by phone for the reconvened meeting.
- The adjournment indicates a need for more votes to proceed with the Annual Meeting's agenda.
- Stockholders have the opportunity to participate in the decision-making process virtually.
The adjournment of the Annual Meeting provides stockholders with additional time to vote and participate in crucial decisions for Salarius Pharmaceuticals.